Twitter

Archive for August 10th, 2012


We Know About Skin Cancer More

Nodular melanoma is very aggressive but is not very common in the U.S.A. It is found on men most often, usually in males over age 60. It grows very quickly and penetrates the skin rather than spreading over it. It occurs completely on its own and doesn’t materialize from an existing mole. It is dark [...]

Read More...

Could coffee cut risk of skin cancer?

A new study finds coffee drinkers could cut their risk of developing basal cell carcinoma – a common form of skin cancer. For more CNN videos, check out our YouTube channel at www.youtube.com Or visit our site at www.cnn.com

Read More...

CNN: Our own Brooke Baldwin had skin cancer

CNN’s Brooke Baldwin addresses the Twitter buzz surrounding her absence and the bandage on her nose.

Read More...

Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson’s Disease

Conditions :   Parkinson Disease;   Parkinsonian Disorders;   Basal Ganglia Diseases;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Movement Disorders;   Neurodegenerative Diseases Interventions :   Dietary Supplement: Whey protein;   Dietary Supplement: Soy protein Sponsors :   Chulalongkorn University;   Chulalongkorn University Recruiting – verified August 2012

Read More...

Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease

Conditions :   Pilonidal Sinus;   Sinus; Dermal, Pilonidal;   Umbilical Granuloma Interventions :   Procedure: Surgery;   Other: conservative Sponsors :   Medical Park Gaziantep Hospital;   Medical Park Gaziantep Hospital;   Zeugma Saglik Hizmetleri San. Tic. Ltd. Sti. Completed – verified August 2012

Read More...

Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

Condition :   Multiple Myeloma Intervention :   Drug: High-Dose Melphalan HCL for Injection (Propylene Glycol-Free) Sponsors :   Ligand Pharmaceuticals;   Ligand Pharmaceuticals;   Clinipace LTD;   Kansas City Bioanalytical Laboratories;   Beckloff Associates, Inc. Not yet recruiting – verified August 2012

Read More...

This Study Will be a Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

Condition :   Chronic Phase Chronic Myeloid Leukemia Intervention :   Drug: Dasatinib Sponsors :   Bristol-Myers Squibb;   Bristol-Myers Squibb Not yet recruiting – verified August 2012

Read More...

Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)

Condition :   Leukemia, Myeloid, Acute Intervention :   Drug: Volasertib Sponsors :   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals Recruiting – verified August 2012

Read More...

Rituximab or Zevalin – Efficacy Trial of Therapeutic Alternatives (RoZetta)

Condition :   Follicular Lymphoma Interventions :   Drug: Zevalin;   Drug: Rituximab Sponsors :   Spectrum Pharmaceuticals, Inc;   Spectrum Pharmaceuticals, Inc Not yet recruiting – verified August 2012

Read More...

Anti-Angiogenic Therapy Post Transplant (ASCR) for Relapsed and Refractory Pediatric Solid Tumors

Conditions :   Glioma;   Neuroectodermal Tumors, Primitive;   Wilms Tumor;   Rhabdomyosarcoma;   Sarcoma, Ewing;   Osteosarcoma;   Retinoblastoma Interventions :   Other: Control;   Drug: Metronomic Cyclophosphamide;   Drug: Thalomide Sponsors :   Washington University School of Medicine;   Washington University School of Medicine Not yet recruiting – verified August 2012

Read More...